http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-336690-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d629f98a51b15993f56f9e04fdea237f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 1967-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1968-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-336690-A1
titleOfInvention A PROCEDURE FOR THE PREPARATION OF 3-CYCLOPENTENYL-2H - 1,2,4-BENZOTIADIAZINE - 1,1 - BIOXIDES.
abstract Novel 3 - cyclopentenyl - 2H - 1,2,4 - benzothiadiazine - 1,1 - dioxides having a chloro, bromo, trifluoromethyl, nitro or methyl substituent in each of the 6- and 7-positions thereof, with the proviso that when one of the said positions is substituted by nitro or methyl the other is substituted by chloro, bromo or trifluoromethyl, and their tautomers and non- toxic salts are prepared (i) by subjecting a compound of the general formula wherein A together with the-C = C- double bond represents a phenylene radical having in the 5-position thereof a substituent X and in the 4-position thereof a substituent Y, where X and Y are each chloro, bromo, trifluoromethyl, nitro or methyl, with the proviso that when one of X and Y is nitro or methyl the other is chloro, bromo or trifluoromethyl Q is (H, H), (H, | | | # RCO), (RCO, RCO) or RCOR1, wherein R is cyclopentenyl and R1 is alkyl T is hydrogen or RCO and Z is hydrogen, benzyl, cyclopentenyl or alkyl, to a condensation reaction, optionally in the presence of a second reactant of the formula R-C#B, wherein B represents from one to three functional groups, in the case when in the first formula above Q is (H, H) and T is hydrogen, followed optionally by conversion to a non-toxic salt of the product or (ii) by subjecting a corresponding 3,4-dihydro-1,2,4- benzothiadiazine - 1,1 - dioxide to dehydrogenation or dehydrohalogenation to introduce a double bond between the atoms in the 3- and 4-positions. Ethyl ortho-3-cyclopentene-1-carboxylate is prepared by reacting an imino ester hydrochloride of cyclopentene with ethanol. 2 - (2- and 3 - Cyclopentene - 1 - carboxamido)- 4,5 - dichlorobenzenesulphonamides are prepared by reacting 2- or 3-cyclopentene-1-carboxylic acid with oxalyl chloride and then 2-amino-4,5- dichloro-benzenesulphonamide. Pharmaceutical compositions having antihypertensive activity comprise as active ingredient a novel 3-cyclopentenyl-2H-1,2,4- benzothiadiazine - 1,1 - dioxide as defined above in admixture with a therapeutically acceptable carrier.
priorityDate 1966-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415875427
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID104383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID204803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456412313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410524705
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID398247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID217864
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID549171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455695671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID120220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393277
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23274597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415820663
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525331
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423099358
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID853756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410524677
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65578
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410

Total number of triples: 45.